Ministers should review the use of a widely used anti-flu medication, scientists have said after new research has questioned the efficacy of the drug. The Government may have wasted hundreds of millions on stockpiling Tamiflu, the report added.
Both the Department of Health and pharmaceutical company Roche have defended the anti-flu drug Tamiflu after research questioned the efficacy of the drug.
A Department of Health spokeswoman said: "The UK is recognised by the World Health Organisation as being one of the best prepared countries in the world for a potential flu pandemic. Our stockpile of antivirals is a key part of this.
"Tamiflu is licensed around the world for the treatment of seasonal flu and is a licensed product with a proven record of safety, quality and efficacy. We regularly review all published data and will consider the Cochrane review closely."
Meanwhile, UK medical director Dr Daniel Thurley at manufacturers Roche said: "We disagree with the overall conclusions of this report.
"Roche stands behind the wealth of data for Tamiflu and the decisions of public health agencies worldwide, including the US and European Centres for Disease Control and Prevention and the World Health Organisation."
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.